From: A pilot trial on safety and efficacy of erythrocyte-mediated steroid treatment in CF patients
Erythrocyte mediated steroid therapy | Ordinary therapy | P value | |
---|---|---|---|
FEV1 at enrolment (-12 months), average (95% CI) | 53.8 (25.6–82.0) | 56.8 (30.0–83.6) | 0.68 |
FEV1 at time +12, average (95% CI) | 56.7 (23.8–89.6) | 55.1 (26.5–83.7) | 0.83 |
FEV1 at time +24, average (95% CI) | 59.8 (22.4–97.2) | 53.2 (21.7–84.7) | 0.48 |